Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published January 16, 2021 | Version v1
Journal article Open

STUDYING NATURE, RISK STRATIFICATION AND DRUGS IMPACT ON ARRHYTHMOGENIC RIGHT CARDIOMYOPATHY

Description

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a form of cardiomyopathy that mostly occurs in young seemingly healthy individuals and athletes, causing sudden cardiac death and ventricular tachyarrhythmias [1]. The illness is described by limited or diffuse decay of prevalently right ventricular myocardium with resulting substitution by greasy and stringy tissue [2,3]. These underlying irregularities are principally situated in the surge plot, summit, and sub tricuspid zone of the privilege ventricular free divider [4].

Files

320.T-Studying Nature, Risk Stratification and Drugs impact on Arrhythmogenic Right Cardiomyopathy.pdf